Cargando…
Is there a Role for Cyclophilin Inhibitors in the Management of Primary Biliary Cirrhosis?
Autoimmune hepatitis (AIH) and primary biliary cirrhosis (PBC) are poorly understood autoimmune liver diseases. Immunosuppression is used to treat AIH and ursodeoxycholic acid is used to slow the progression of PBC. Nevertheless, a proportion of patients with both disorders progress to liver failure...
Autores principales: | Wasilenko, Shawn T., Montano-Loza, Aldo J., Mason, Andrew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3640509/ https://www.ncbi.nlm.nih.gov/pubmed/23348060 http://dx.doi.org/10.3390/v5020423 |
Ejemplares similares
-
Characterization of a human betaretrovirus in patients with primary biliary cirrhosis
por: Wang, Weiwei, et al.
Publicado: (2014) -
Recurrence of primary biliary cholangitis after liver transplantation: A Japanese perspective
por: Montano‐Loza, Aldo J., et al.
Publicado: (2017) -
Isolation of a human betaretrovirus resembling mouse mammary tumor virus (MMTV) from patients with primary biliary cirrhosis
por: Indik, Stan, et al.
Publicado: (2009) -
Impact of combination antiretroviral therapy in the NOD.c3c4 mouse model of autoimmune biliary disease
por: Sharon, David, et al.
Publicado: (2015) -
Primary biliary cirrhosis
por: Hohenester, Simon, et al.
Publicado: (2009)